Richard S. Schottenfeld

8.2k total citations
153 papers, 6.4k citations indexed

About

Richard S. Schottenfeld is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Richard S. Schottenfeld has authored 153 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Public Health, Environmental and Occupational Health, 81 papers in Epidemiology and 28 papers in Pharmacology. Recurrent topics in Richard S. Schottenfeld's work include Opioid Use Disorder Treatment (79 papers), Substance Abuse Treatment and Outcomes (67 papers) and HIV, Drug Use, Sexual Risk (27 papers). Richard S. Schottenfeld is often cited by papers focused on Opioid Use Disorder Treatment (79 papers), Substance Abuse Treatment and Outcomes (67 papers) and HIV, Drug Use, Sexual Risk (27 papers). Richard S. Schottenfeld collaborates with scholars based in United States, China and Malaysia. Richard S. Schottenfeld's co-authors include Patrick G. O’Connor, Marek C. Chawarski, David A. Fiellin, Declan T. Barry, Brent A. Moore, Thomas R. Kosten, Lynn E. Sullivan, Michael V. Pantalon, Juliana Pakes and Christopher J. Cutter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Richard S. Schottenfeld

152 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard S. Schottenfeld United States 46 3.4k 3.4k 1.1k 1.1k 826 153 6.4k
Robert Ali Australia 45 3.5k 1.0× 4.4k 1.3× 1.1k 1.0× 1.3k 1.2× 877 1.1× 183 8.6k
Elinore F. McCance‐Katz United States 42 2.2k 0.6× 2.1k 0.6× 1.2k 1.1× 963 0.9× 1.1k 1.3× 116 5.6k
Andrew J. Saxon United States 41 2.6k 0.8× 2.7k 0.8× 777 0.7× 890 0.8× 671 0.8× 222 6.2k
Patrick G. O’Connor United States 48 4.9k 1.4× 4.8k 1.4× 1.2k 1.1× 1.1k 1.1× 419 0.5× 148 9.0k
Brent A. Moore United States 41 1.7k 0.5× 2.4k 0.7× 722 0.6× 1.7k 1.6× 455 0.6× 109 5.2k
Eric C. Strain United States 48 4.1k 1.2× 2.9k 0.9× 1.0k 0.9× 2.2k 2.0× 1.5k 1.8× 199 8.7k
Andrew Rosenblum United States 42 2.3k 0.7× 2.5k 0.7× 700 0.6× 659 0.6× 304 0.4× 141 6.0k
Jo Kimber Australia 31 4.5k 1.3× 4.6k 1.4× 1.3k 1.1× 579 0.5× 303 0.4× 56 6.4k
Sharon Walsh United States 47 4.5k 1.3× 2.5k 0.7× 1.1k 0.9× 1.9k 1.7× 2.2k 2.7× 191 9.5k
Joanne Ross Australia 50 3.1k 0.9× 3.9k 1.1× 759 0.7× 808 0.8× 438 0.5× 127 6.5k

Countries citing papers authored by Richard S. Schottenfeld

Since Specialization
Citations

This map shows the geographic impact of Richard S. Schottenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Schottenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Schottenfeld more than expected).

Fields of papers citing papers by Richard S. Schottenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Schottenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Schottenfeld. The network helps show where Richard S. Schottenfeld may publish in the future.

Co-authorship network of co-authors of Richard S. Schottenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Schottenfeld. A scholar is included among the top collaborators of Richard S. Schottenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Schottenfeld. Richard S. Schottenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barry, Declan T., Mark Beitel, Christopher J. Cutter, et al.. (2021). Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder. Drug and Alcohol Dependence. 221. 108608–108608. 5 indexed citations
2.
Beitel, Mark, Joseph P. Gone, Jacques P. Barber, et al.. (2018). Psychotherapy with American Indians: An exploration of therapist-rated techniques in three urban clinics.. Psychotherapy. 55(1). 45–51. 5 indexed citations
3.
Getachew, Bruk, et al.. (2018). Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. BMC Microbiology. 18(1). 222–222. 97 indexed citations
4.
Vicknasingam, Balasingam, et al.. (2015). Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. Drug and Alcohol Dependence. 152. 164–169. 9 indexed citations
5.
Cutter, Christopher J., Richard S. Schottenfeld, Brent A. Moore, et al.. (2014). A pilot trial of a videogame-based exercise program for methadone maintained patients. Journal of Substance Abuse Treatment. 47(4). 299–305. 45 indexed citations
6.
Edelman, E. Jennifer, Brent A. Moore, Kathleen J. Sikkema, et al.. (2014). HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment. Drug and Alcohol Dependence. 140. e54–e54. 3 indexed citations
7.
Fiellin, David A., et al.. (2014). Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependence. Drug and Alcohol Dependence. 146. e277–e277. 2 indexed citations
8.
Schottenfeld, Richard S., Brent A. Moore, & Michael V. Pantalon. (2011). Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug and Alcohol Dependence. 118(1). 48–55. 43 indexed citations
9.
Sullivan, Lynn E., Michael Botsko, Chinazo O. Cunningham, et al.. (2011). The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 1). S54–S61. 27 indexed citations
10.
Barry, Declan T., Mark Beitel, Christopher J. Cutter, et al.. (2010). Conventional and Unconventional Treatments for Stress among Methadone-Maintained Patients: Treatment Willingness and Perceived Efficacy. American Journal on Addictions. 20(2). no–no. 7 indexed citations
11.
Vicknasingam, Balasingam, et al.. (2010). Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia. Drug and Alcohol Dependence. 111(1-2). 44–49. 45 indexed citations
12.
Chawarski, Marek C., et al.. (1999). Plasma concentrations of buprenorphine 24 to 72 hours after dosing. Drug and Alcohol Dependence. 55(1-2). 157–163. 42 indexed citations
13.
Mayes, Linda C., Christian Grillon, Richard Granger, & Richard S. Schottenfeld. (1998). Regulation of Arousal and Attention in Preschool Children Exposed to Cocaine Prenatally. Annals of the New York Academy of Sciences. 846(1). 126–143. 139 indexed citations
14.
O’Connor, Patrick G., Kathleen M. Carroll, Julia Shi, et al.. (1997). Three Methods of Opioid Detoxification in a Primary Care Setting. Annals of Internal Medicine. 38 indexed citations
15.
Oliveto, Alison, Thomas R. Kosten, Richard S. Schottenfeld, Jean Falcioni, & Douglas Ziedonis. (1995). Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. Journal of Substance Abuse Treatment. 12(6). 423–428. 22 indexed citations
16.
Malakoff, Marguerite E., Linda C. Mayes, & Richard S. Schottenfeld. (1994). Language Abilities of Preschool‐Age Children Living With Cocaine‐Using Mothers. American Journal on Addictions. 3(4). 346–354. 14 indexed citations
17.
Kosten, Thomas R., Frank H. Gawin, Therese A. Kosten, et al.. (1992). Six‐Month Follow‐Up of Short‐Term Pharmacotherapy for Cocaine Dependence. American Journal on Addictions. 1(1). 40–49. 32 indexed citations
18.
O’Connor, Patrick G., et al.. (1992). Human immunodeficiency virus infection in intravenous drug users: A model for primary care. The American Journal of Medicine. 93(4). 382–386. 71 indexed citations
19.
Schottenfeld, Richard S., et al.. (1992). Treatment of dual diagnosis patients: A relapse prevention group approach. Journal of Substance Abuse Treatment. 9(4). 305–309. 22 indexed citations
20.
Schottenfeld, Richard S.. (1989). Involuntary Treatment of Substance Abuse Disorders – Impediments to Success. Psychiatry. 52(2). 164–176. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Ali Breakdown of academic impact, for papers by Elinore F. McCance‐Katz Breakdown of academic impact, for papers by Andrew J. Saxon Breakdown of academic impact, for papers by Patrick G. O’Connor Breakdown of academic impact, for papers by Brent A. Moore Breakdown of academic impact, for papers by Eric C. Strain Breakdown of academic impact, for papers by Andrew Rosenblum Breakdown of academic impact, for papers by Jo Kimber Breakdown of academic impact, for papers by Sharon Walsh Breakdown of academic impact, for papers by Joanne Ross
Rankless by CCL
2026